3 ms·
> We’re talking about treating very, very large populations, which means that you’re going to see the usual run of mortality and morbidity that you see across l
by hunterb123 5y ago
> We’re talking about treating very, very large populations, which means that you’re going to see the usual run of mortality and morbidity that you see across large samples.
Exactly, that's why I said when you scale up you will get more absolute deaths and critical conditions. There's no point for those very few deaths or reactions to occur if those people had better natural immunity through previous infection.
- mapme 5y agoI think you misunderstood the quote. It is saying that if you take 10 million people the background rate of death, disease, stroke etc., (unrelated to vaccine) will be high and a confounding issue, even if you didn’t give them the vaccine. Edit: I think you have a point about whether those who have previous infection truly need the vaccine, but the way you are using VAERS data diminishes your point